Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy

RMD Open. 2022 Feb;8(1):e002082. doi: 10.1136/rmdopen-2021-002082.
No abstract available

Keywords: COVID-19; Tumor necrosis factor inhibitors; infections.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Rheumatic Diseases* / drug therapy
  • SARS-CoV-2
  • Tumor Necrosis Factor Inhibitors
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Tumor Necrosis Factor Inhibitors
  • Vaccines, Synthetic
  • mRNA Vaccines